Search research articles
Contact Us
Filters
Showing results (131-140 of 164) with videos related to
Page
of 17
Sort By:
Nature Genetics
|
September 4, 2012
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Sharon J Diskin, Mario Capasso, Robert W Schnepp, et al.
Oncotarget
|
March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
Vito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Cancer Research Communications
|
April 23, 2024
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma
Carolina Giordano, Laura Marrone, Simona Romano, et al.
ESMO Open
|
September 11, 2020
Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, et al.
Nutrients
|
August 14, 2025
The Ten Dietary Commandments for Patients with Irritable Bowel Syndrome: A Narrative Review with Pragmatic Indications
Nicola Siragusa, Gloria Baldassari, Lorenzo Ferrario, et al.
Cancers
|
February 11, 2023
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology
Fabio Pastorino, Mario Capasso, Chiara Brignole, et al.
International Journal of Molecular Sciences
|
September 10, 2021
The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism
Marianna Caterino, Michele Costanzo, Roberta Fedele, et al.
Molecular Cancer Therapeutics
|
April 27, 2018
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
Viktoryia Sidarovich, Marilena De Mariano, Sanja Aveic, et al.
International Journal of Molecular Sciences
|
January 28, 2026
Targeted Therapy for a Rare <i>PDGFRB</i>-Rearranged Myeloproliferative Neoplasm: A Case Report
Cosimo Barbato, Vito A Lasorsa, Francesco Grimaldi, et al.
American Journal of Hematology
|
July 6, 2026
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia
Anthony Iscaro, Simona Leoni, Filippo Russo, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 164) with videos related to
Sort By:
Page
of 17
Nature Genetics
|
September 4, 2012
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Sharon J Diskin, Mario Capasso, Robert W Schnepp, et al.
Oncotarget
|
March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
Vito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Cancer Research Communications
|
April 23, 2024
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma
Carolina Giordano, Laura Marrone, Simona Romano, et al.
ESMO Open
|
September 11, 2020
Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, et al.
Nutrients
|
August 14, 2025
The Ten Dietary Commandments for Patients with Irritable Bowel Syndrome: A Narrative Review with Pragmatic Indications
Nicola Siragusa, Gloria Baldassari, Lorenzo Ferrario, et al.
Cancers
|
February 11, 2023
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology
Fabio Pastorino, Mario Capasso, Chiara Brignole, et al.
International Journal of Molecular Sciences
|
September 10, 2021
The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism
Marianna Caterino, Michele Costanzo, Roberta Fedele, et al.
Molecular Cancer Therapeutics
|
April 27, 2018
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
Viktoryia Sidarovich, Marilena De Mariano, Sanja Aveic, et al.
International Journal of Molecular Sciences
|
January 28, 2026
Targeted Therapy for a Rare <i>PDGFRB</i>-Rearranged Myeloproliferative Neoplasm: A Case Report
Cosimo Barbato, Vito A Lasorsa, Francesco Grimaldi, et al.
American Journal of Hematology
|
July 6, 2026
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia
Anthony Iscaro, Simona Leoni, Filippo Russo, et al.
Page
of 17